During the past decade, Inha University Hospital conducted 149 clinical trials. In the 10-year time frame, 149 clinical trials started and 42 clinical trials were completed, i.e. on average, 28.2% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 30 clinical trials were completed. i.e. 49.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inha University Hospital" #1 sponsor was "Inha University Hospital" with 18 trials, followed by "Hoffmann-La Roche" with 17 trials sponsored, "Pfizer" with 11 trials sponsored, "Boryung Pharmaceutical Co., Ltd" with 8 trials sponsored and "Eli Lilly and Company" with 8 trials sponsored. Other sponsors include 171 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inha University Hospital" #1 collaborator was "Inha University Hospital" with 13 trials as a collaborator, "Inje University" with 7 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 6 trials as a collaborator, "Hallym University Medical Center" with 6 trials as a collaborator and "GlaxoSmithKline" with 5 trials as a collaborator. Other collaborators include 159 different institutions and companies that were collaborators in the rest 116 trials.

According to Clinical.Site data, the most researched conditions in "Inha University Hospital" are "Coronary Artery Disease" (11 trials), "Breast Cancer" (10 trials), "Alzheimer's Disease" (9 trials), "Hepatocellular Carcinoma" (6 trials) and "Type 2 Diabetes Mellitus" (6 trials). Many other conditions were trialed in "Inha University Hospital" in a lesser frequency.

Most popular intervention types in "Inha University Hospital" are "Drug" (153 trials), "Biological" (33 trials), "Device" (26 trials), "Other" (16 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Cilostazol" (4 trials), "Gantenerumab" (4 trials), "Paclitaxel" (4 trials) and "Abemaciclib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Inha University Hospital" are 225 trials for "All" genders, 9 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Inha University Hospital". undefined are not yet recruiting, 28 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 129 completed trials in Inha University Hospital, undefined suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Inha University Hospital, 23 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 24 trials that are defined as “Not Applicable".